Jihui Hao

4.6k total citations
117 papers, 3.1k citations indexed

About

Jihui Hao is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jihui Hao has authored 117 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 54 papers in Molecular Biology and 34 papers in Cancer Research. Recurrent topics in Jihui Hao's work include Pancreatic and Hepatic Oncology Research (44 papers), Cancer, Hypoxia, and Metabolism (20 papers) and Cancer Genomics and Diagnostics (11 papers). Jihui Hao is often cited by papers focused on Pancreatic and Hepatic Oncology Research (44 papers), Cancer, Hypoxia, and Metabolism (20 papers) and Cancer Genomics and Diagnostics (11 papers). Jihui Hao collaborates with scholars based in China, United States and United Kingdom. Jihui Hao's co-authors include Xiuchao Wang, He Ren, Shengyu Yang, Chongbiao Huang, Tiansuo Zhao, Guangjun Nie, Xiao Zhao, He Ren, Yiye Li and Tianjiao Ji and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Jihui Hao

110 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jihui Hao China 32 1.4k 1.2k 792 590 442 117 3.1k
Zhuan Zhou China 32 2.0k 1.4× 698 0.6× 635 0.8× 371 0.6× 246 0.6× 81 3.0k
Pilar de la Puente United States 22 1.2k 0.8× 717 0.6× 855 1.1× 324 0.5× 259 0.6× 50 2.7k
Kyoko Hida Japan 34 2.5k 1.7× 956 0.8× 1.3k 1.6× 368 0.6× 501 1.1× 65 3.5k
Barbara Muz United States 22 1.3k 0.9× 770 0.7× 913 1.2× 484 0.8× 184 0.4× 58 2.8k
Rodney B. Luwor Australia 32 2.0k 1.4× 1.5k 1.2× 867 1.1× 485 0.8× 187 0.4× 95 3.7k
Jay S. Desgrosellier United States 19 2.7k 1.9× 1.6k 1.4× 770 1.0× 759 1.3× 416 0.9× 30 4.9k
Antonio Daga Italy 35 2.3k 1.6× 1.3k 1.1× 779 1.0× 727 1.2× 176 0.4× 96 4.2k
Shamit K. Dutta United States 31 1.6k 1.1× 723 0.6× 565 0.7× 256 0.4× 338 0.8× 62 2.6k
Holly E. Barker United Kingdom 16 1.8k 1.3× 1.7k 1.4× 839 1.1× 638 1.1× 190 0.4× 27 3.9k

Countries citing papers authored by Jihui Hao

Since Specialization
Citations

This map shows the geographic impact of Jihui Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jihui Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jihui Hao more than expected).

Fields of papers citing papers by Jihui Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jihui Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jihui Hao. The network helps show where Jihui Hao may publish in the future.

Co-authorship network of co-authors of Jihui Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Jihui Hao. A scholar is included among the top collaborators of Jihui Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jihui Hao. Jihui Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Cai, Wenhui Zhao, Duo Zuo, et al.. (2025). AI‐Guided SERS Defines a Pan‐Cancer Diagnostic Biomarker. Advanced Science. 13(7). e16268–e16268.
2.
Jiang, Wenna, Meng Wang, Jiayi Wang, et al.. (2025). β-Hydroxybutyrate promotes cancer metastasis through β-hydroxybutyrylation-dependent stabilization of Snail. Nature Communications. 16(1). 6592–6592. 3 indexed citations
3.
Liu, Rui, Zhi Ji, Xia Wang, et al.. (2025). Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial. Nature Communications. 16(1). 1481–1481. 5 indexed citations
4.
Zhang, Xinxin, Xiaoteng Cui, Peiying Li, et al.. (2024). EGC enhances tumor antigen presentation and CD8+ T cell-mediated antitumor immunity via targeting oncoprotein SND1. Cancer Letters. 592. 216934–216934. 5 indexed citations
5.
6.
Li, Jianming, Tiansuo Zhao, Xiuchao Wang, et al.. (2024). BICC1 drives pancreatic cancer stemness and chemoresistance by facilitating tryptophan metabolism. Science Advances. 10(25). eadj8650–eadj8650. 15 indexed citations
7.
Zou, Yiping, et al.. (2023). A new staging system for postoperative prognostication in pancreatic ductal adenocarcinoma. iScience. 26(9). 107589–107589. 1 indexed citations
8.
Sun, Huizhi, Yanlei Li, Yanhui Zhang, et al.. (2023). The relevance between hypoxia-dependent spatial transcriptomics and the prognosis and efficacy of immunotherapy in claudin-low breast cancer. Frontiers in Immunology. 13. 1042835–1042835. 14 indexed citations
9.
Zhao, Tiansuo, Fanyang Kong, Xiangyu Kong, et al.. (2023). Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 29(24). 5183–5195. 9 indexed citations
10.
Zou, Yiping, Tianxing Zhou, Yongjie Xie, et al.. (2023). Survival outcomes of neoadjuvant therapy followed by radical resection versus upfront surgery for stage I–III pancreatic ductal adenocarcinoma: a retrospective cohort study. International Journal of Surgery. 109(6). 1573–1583. 5 indexed citations
11.
Liu, Weishuai, Xiaozhou Yu, Yixing Feng, et al.. (2022). CD73, a Promising Therapeutic Target of Diclofenac, Promotes Metastasis of Pancreatic Cancer through a Nucleotidase Independent Mechanism. Advanced Science. 10(6). e2206335–e2206335. 22 indexed citations
12.
Fan, Xiaoying, Ping Lü, Hongwei Wang, et al.. (2022). Integrated single-cell multiomics analysis reveals novel candidate markers for prognosis in human pancreatic ductal adenocarcinoma. Cell Discovery. 8(1). 13–13. 38 indexed citations
13.
Wang, Xiuchao, Yunzhan Li, Zekun Li, et al.. (2022). Mitochondrial Calcium Uniporter Drives Metastasis and Confers a Targetable Cystine Dependency in Pancreatic Cancer. Cancer Research. 82(12). 2254–2268. 76 indexed citations
14.
Zhou, Tianxing, Jing Liu, Yongjie Xie, et al.. (2021). ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4. Gut. 71(2). 357–371. 33 indexed citations
15.
Huang, Chongbiao, Yang Li, Zengxun Li, et al.. (2019). LIMS1 Promotes Pancreatic Cancer Cell Survival under Oxygen–Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation. Clinical Cancer Research. 25(13). 4091–4103. 43 indexed citations
16.
Lin, Shengchen, Chongbiao Huang, Venugopal Gunda, et al.. (2019). Fascin Controls Metastatic Colonization and Mitochondrial Oxidative Phosphorylation by Remodeling Mitochondrial Actin Filaments. Cell Reports. 28(11). 2824–2836.e8. 55 indexed citations
17.
Gao, Song, Yan Sun, Limei Hu, et al.. (2016). IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma. Cancer Research. 76(22). 6543–6554. 88 indexed citations
18.
Zhao, Tiansuo, Wenna Jiang, Xiuchao Wang, et al.. (2016). ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin. Cancer Research. 77(4). 874–885. 45 indexed citations
19.
Wang, Xiuchao, Shasha Li, Jun Sheng, et al.. (2011). Expression of hypoxia-inducible factor-2α in hepatocellular carcinoma and its clinical significance. Clinical Oncology and Cancer Research. 38(10). 560–563. 2 indexed citations
20.
Hao, Jihui, Ming Yu, Jia Li, et al.. (2007). Synergistic effects of proteasome inhibitor on TRAIL-induced apoptosis in malignant lymphoma cells. Clinical Oncology and Cancer Research. 34(3). 129–131. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhuan Zhou Breakdown of academic impact, for papers by Pilar de la Puente Breakdown of academic impact, for papers by Kyoko Hida Breakdown of academic impact, for papers by Barbara Muz Breakdown of academic impact, for papers by Rodney B. Luwor Breakdown of academic impact, for papers by Jay S. Desgrosellier Breakdown of academic impact, for papers by Antonio Daga Breakdown of academic impact, for papers by Shamit K. Dutta Breakdown of academic impact, for papers by Holly E. Barker
Rankless by CCL
2026